Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in Children

NCT01323972 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

327

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria

Interventions

BIOLOGICAL: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine (257049)

Sponsor

GlaxoSmithKline

Collaborators

[object Object]